Free Trial

MarketBeat Instant News Alerts

Amylyx Pharmaceuticals logo with Medical background

Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus

Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric hypoglycemia, or PBH, with data from the LUCIDITY trial expected in the third quarter, Co-Chief Executive Officer Joshua Cohen said at the BofA Annual Healthcare Conferenc

NASDAQ:AMLX
Read Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus
Olin logo with Basic Materials background

Olin Q1 Earnings Call Highlights

Olin (NYSE:OLN) executives said the company expects a sharp sequential improvement in second-quarter earnings as higher pricing, seasonal demand and cost reductions begin to flow through results following a challenging but improving first quarter. Speaking on Olin’s first-quarter 2026 earnings call

NYSE:OLN
Read Olin Q1 Earnings Call Highlights
JBS logo with Manufacturing background

JBS Q1 Earnings Call Highlights

JBS (NYSE:JBS) reported record first-quarter sales but lower profitability as executives said the global protein company faced difficult market conditions in U.S. beef, seasonal pressures, operational adjustments and shifting trade flows. Global CEO Gilberto Tomazoni said the first quarter of 2026

NYSE:JBS
Read JBS Q1 Earnings Call Highlights
Infinity Natural Resources logo with Basic Materials background

Infinity Natural Resources Q1 Earnings Call Highlights

Infinity Natural Resources (NYSE:INR) said its first quarter was marked by a significant expansion of its Appalachian footprint, following the late-February closing of its acquisition of Antero’s Ohio Utica assets and the addition of working interests in Pennsylvania through the Chase acquisition.

NYSE:INR
Read Infinity Natural Resources Q1 Earnings Call Highlights
Doximity logo with Services background

Doximity Q4 Earnings Call Highlights

Doximity (NYSE:DOCS) reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market r

NYSE:DOCS
Read Doximity Q4 Earnings Call Highlights
BTGO logo with background

BTGO Q1 Earnings Call Highlights

BitGo (NYSE:BTGO) reported sharply higher first-quarter revenue from a year earlier but a wider GAAP loss, as executives said softer digital asset market conditions and accounting treatment for new derivatives activity made headline results less reflective of the company’s underlying business trends

NYSE:BTGO
Read BTGO Q1 Earnings Call Highlights

Trending News

All MarketBeat Instant News Alerts

Wrap Technologies logo with Industrials background

Wrap Technologies Q1 Earnings Call Highlights

NASDAQ:WRAP
Read Wrap Technologies Q1 Earnings Call Highlights
Energous logo with Industrials background

Energous Q1 Earnings Call Highlights

NASDAQ:WATT
Read Energous Q1 Earnings Call Highlights
USA Rare Earth logo with Basic Materials background

USA Rare Earth Q1 Earnings Call Highlights

NASDAQ:USAR
Read USA Rare Earth Q1 Earnings Call Highlights
STAAR Surgical logo with Medical background

STAAR Surgical Q1 Earnings Call Highlights

NASDAQ:STAA
Read STAAR Surgical Q1 Earnings Call Highlights
Seer logo with Medical background

Seer Q1 Earnings Call Highlights

NASDAQ:SEER
Read Seer Q1 Earnings Call Highlights
Sangoma Technologies logo with Computer and Technology background

Sangoma Technologies Q3 Earnings Call Highlights

NASDAQ:SANG
Read Sangoma Technologies Q3 Earnings Call Highlights
Rapid Micro Biosystems logo with Medical background

Rapid Micro Biosystems Q1 Earnings Call Highlights

NASDAQ:RPID
Read Rapid Micro Biosystems Q1 Earnings Call Highlights
QT Imaging logo with Medical background

QT Imaging Q1 Earnings Call Highlights

NASDAQ:QTI
Read QT Imaging Q1 Earnings Call Highlights
Precigen logo with Medical background

Precigen Q1 Earnings Call Highlights

NASDAQ:PGEN
Read Precigen Q1 Earnings Call Highlights
Omeros logo with Medical background

Omeros Q1 Earnings Call Highlights

NASDAQ:OMER
Read Omeros Q1 Earnings Call Highlights
Vinci Compass Investments logo with Finance background

Vinci Compass Investments (NASDAQ:VINP) CFO Sells $16,306.00 in Stock

NASDAQ:VINP
Read Vinci Compass Investments (NASDAQ:VINP) CFO Sells $16,306.00 in Stock
Vinci Compass Investments logo with Finance background

Sergio Passos Ribeiro Sells 1,970 Shares of Vinci Compass Investments (NASDAQ:VINP) Stock

NASDAQ:VINP
Read Sergio Passos Ribeiro Sells 1,970 Shares of Vinci Compass Investments (NASDAQ:VINP) Stock
Vinci Compass Investments logo with Finance background

Vinci Compass Investments (NASDAQ:VINP) Insider Fernando Lovisotto Sells 4,310 Shares

NASDAQ:VINP
Read Vinci Compass Investments (NASDAQ:VINP) Insider Fernando Lovisotto Sells 4,310 Shares
Vinci Compass Investments logo with Finance background

Insider Selling: Vinci Compass Investments (NASDAQ:VINP) Insider Sells 4,476 Shares of Stock

NASDAQ:VINP
Read Insider Selling: Vinci Compass Investments (NASDAQ:VINP) Insider Sells 4,476 Shares of Stock
Vinci Compass Investments logo with Finance background

Vinci Compass Investments (NASDAQ:VINP) Insider Sells $58,549.13 in Stock

NASDAQ:VINP
Read Vinci Compass Investments (NASDAQ:VINP) Insider Sells $58,549.13 in Stock
Mineralys Therapeutics logo with Medical background

David Malcom Rodman Sells 2,171 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

NASDAQ:MLYS
Read David Malcom Rodman Sells 2,171 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock
Vinci Compass Investments logo with Finance background

Bruno Augusto Sacchi Zaremba Sells 9,305 Shares of Vinci Compass Investments (NASDAQ:VINP) Stock

NASDAQ:VINP
Read Bruno Augusto Sacchi Zaremba Sells 9,305 Shares of Vinci Compass Investments (NASDAQ:VINP) Stock
Mineralys Therapeutics logo with Medical background

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 6,348 Shares of Stock

NASDAQ:MLYS
Read Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 6,348 Shares of Stock
Mineralys Therapeutics logo with Medical background

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 14,056 Shares of Stock

NASDAQ:MLYS
Read Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 14,056 Shares of Stock
Microvision logo with Computer and Technology background

Microvision Q1 Earnings Call Highlights

NASDAQ:MVIS
Read Microvision Q1 Earnings Call Highlights
MDxHealth logo with Medical background

MDxHealth Q1 Earnings Call Highlights

NASDAQ:MDXH
Read MDxHealth Q1 Earnings Call Highlights
Marchex logo with Computer and Technology background

Marchex Q1 Earnings Call Highlights

NASDAQ:MCHX
Read Marchex Q1 Earnings Call Highlights
Lightwave Logic logo with Basic Materials background

Lightwave Logic Q1 Earnings Call Highlights

NASDAQ:LWLG
Read Lightwave Logic Q1 Earnings Call Highlights
AEye logo with Computer and Technology background

AEye Q1 Earnings Call Highlights

NASDAQ:LIDR
Read AEye Q1 Earnings Call Highlights

Featured Articles and Offers

Alert Categories

All Alerts